Stay updated on HMPL-813 in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HMPL-813 in Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the HMPL-813 (epitinib) glioblastoma study is displayed, including its design, eligibility criteria, outcome measure, and recruiting locations. The prior access-denied message is no longer shown.
    Difference
    44%
    Check dated 2026-11-10T17:51:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T18:14:42.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2. The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T19:40:06.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:19:38.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error. The previous study content and navigation are replaced by an access-denied screen.
    Difference
    17%
    Check dated 2026-09-22T23:06:56.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page shows a new revision number, updating from v3.6.6 to v3.7.0, indicating a newer release of the ClinicalTrials.gov page. This upgrade appears to be a general page update rather than a change to the study content or fields.
    Difference
    0.1%
    Check dated 2026-09-15T21:48:26.000Z thumbnail image

Stay in the know with updates to HMPL-813 in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HMPL-813 in Glioblastoma Clinical Trial page.